{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:26:56Z","timestamp":1773664016317,"version":"3.50.1"},"reference-count":94,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC"},{"name":"Merck & Co., Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.1080\/14737167.2026.2626567","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:47:02Z","timestamp":1770364022000},"page":"397-406","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Impact of an expanded male catch-up HPV vaccination program on the clinical and economic burden of HPV-associated diseases in Denmark: a modeling study"],"prefix":"10.1080","volume":"26","author":[{"given":"Emilie","family":"Theisen Honore","sequence":"first","affiliation":[{"name":"Market Access, MSD","place":["Copenhagen, Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-2147","authenticated-orcid":false,"given":"Thomas","family":"Le Fevre","sequence":"additional","affiliation":[{"name":"Market Access, MSD","place":["Copenhagen, Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Pavelyev","sequence":"additional","affiliation":[{"name":"HCL America, Inc","place":["Sunnyvale, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1874-8730","authenticated-orcid":false,"given":"Ugne","family":"Sabale","sequence":"additional","affiliation":[{"name":"Value & Implementation Outcomes Research, MSD","place":["Vilnius, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-8291","authenticated-orcid":false,"given":"Christian","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[{"name":"University Hospital","place":["Copenhagen, Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3226-7231","authenticated-orcid":false,"given":"Vincent","family":"Daniels","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.055"},{"key":"e_1_3_8_5_1","unstructured":"World Health Organization International Agency for Research on Cancer. Age-standardized rate (Nordic) per 100 000 incidence males and females: cervix uteri: Denmark. [cited 2025 Aug 21]. Available from: https:\/\/nordcan.iarc.fr\/en\/dataviz\/trends?cancers=190&sexes=1_2&populations=208&group_cancers=1&multiple_cancers=1"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35099"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494816653669"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e13108"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.007"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28963"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.07.018"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv403"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.06.033"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01097-3"},{"key":"e_1_3_8_15_1","unstructured":"European Medicines Agency. Gardasil. [cited 2024 Aug 22]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil"},{"key":"e_1_3_8_16_1","unstructured":"Danish Health and Medicines Authority. Health technology assessment (HTA) on HPV vaccination of boys (consultation version). 2019."},{"key":"e_1_3_8_17_1","unstructured":"Statens Serum Institut. Vaccination intervals and adaptation. [cited 2024 Apr 9]. Available from: https:\/\/www.ssi.dk\/vaccinationer\/boernevaccination\/vaccination-mod-livmoderhalskraeft\/vaccinationsintervaller-og-tilpasning"},{"key":"e_1_3_8_18_1","unstructured":"European Medicines Agency. Cervarix. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cervarix"},{"key":"e_1_3_8_19_1","unstructured":"European Medicines Agency. Gardasil 9. [cited 2024 Aug 22]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil-9"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000214924"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.091"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30687-3"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv368"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2064279"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.024"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa099"},{"key":"e_1_3_8_27_1","unstructured":"Statens Serum Institut. Last chance for free HPV vaccination for boys in the catch-up programmes. 2021 [cited 2024 Apr 9]. Available from: https:\/\/www.ssi.dk\/aktuelt\/nyheder\/2021\/sidste-chance-for-gratis-hpv-vaccination-til-drenge-i-catch-up-programmerne"},{"key":"e_1_3_8_28_1","unstructured":"Statens Serum Institut. Vaccination against human papilloma virus (HPV). 2025 [cited 2025 Apr 1]. Available from: https:\/\/www.ssi.dk\/vaccinationer\/boernevaccination\/vaccination-mod-livmoderhalskraeft"},{"key":"e_1_3_8_29_1","unstructured":"Statens Serum Institut. HPV boys complete vaccination. [cited 2025 Aug 21]. Available from: https:\/\/statistik.ssi.dk\/sygdomsdata#!\/?vaccination=16&sex=1&landsdel=100&xaxis=Cohort&show=Graph&datatype=Vaccination"},{"key":"e_1_3_8_30_1","unstructured":"European Medicines Agency. Review concludes evidence does not support that HPV vaccines cause CRPS or POTS 2015. [cited 2025 Aug 21]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/review-concludes-evidence-does-not-support-hpv-vaccines-cause-crps-or-pots"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12694"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2930"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.12.019"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X211003589"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-6268-x"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.021"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.030"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1301.060438"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-119"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2282912"},{"key":"e_1_3_8_41_1","unstructured":"Statens Serum Institut. Monitoring in numbers graphs and maps. Available from: https:\/\/statistik.ssi.dk\/"},{"key":"e_1_3_8_42_1","unstructured":"Statens Serum Institut. Surveillance in numbers graphs and maps [in Danish]. [cited 2026 Jan 21]. Available from: https:\/\/statistik.ssi.dk\/\/sygdomsdata#!\/?vaccination=16&sex=1&landsdel=100&xaxis=Cohort&show=Graph&datatype=Vaccination"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.56181\/VRSX6634"},{"key":"e_1_3_8_44_1","unstructured":"Statens Serum Institut. Last chance for free HPV vaccination for boys in the catch-up programs [in Danish]. 2021 [cited 2026 Jan 21]. Available from: http:\/\/www.ssi.dk\/aktuelt\/nyheder\/2021\/sidste-chance-for-gratis-hpv-vaccination-til-drenge-i-catch-up-programmerne"},{"key":"e_1_3_8_45_1","unstructured":"Statistics Denmark. Find statistics. Available from: https:\/\/www.dst.dk\/en\/Statistik\/"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33893"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-1082"},{"key":"e_1_3_8_48_1","unstructured":"HPV Information Centre. Human papillomavirus and related diseases report: Denmark. 2023."},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-017-0129-6"},{"key":"e_1_3_8_50_1","unstructured":"Sundhedsdatastyrelsen. National health registers. Available from: https:\/\/sundhedsdatastyrelsen.dk\/da\/english\/health_data_and_registers\/national_health_registers"},{"key":"e_1_3_8_51_1","unstructured":"Nordcan. Comparable cancer statistics for Denmark. Finland Iceland Norway Sweden The Faroe Islands and Greenland. Available from: https:\/\/nordcan.iarc.fr\/en"},{"key":"e_1_3_8_52_1","unstructured":"Regionernes Kliniske Kvalitetsudviklingsprogram. Data for research. Available from: https:\/\/www.rkkp.dk\/data-til-forskning\/"},{"key":"e_1_3_8_53_1","unstructured":"L\u00e6gemiddelstyrelsen. Medicinpriser.dk. Available from: https:\/\/medicinpriser.dk\/"},{"key":"e_1_3_8_54_1","unstructured":"Praktiserende L\u00e6gers Organisation. Overenskomst om almen praksis 2022. 2022."},{"key":"e_1_3_8_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-015-0029-9"},{"key":"e_1_3_8_56_1","unstructured":"Sundhedsdatastyrelsen. Danish Interactive DRG. Sundhedsdatastyrelsen. Available from: https:\/\/sundhedsdatastyrelsen.dk\/da\/english\/health_finance"},{"key":"e_1_3_8_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/14034948211058060"},{"key":"e_1_3_8_58_1","unstructured":"Medicinr\u00e5det. Appendiks: Aldersjustering for sundhedsrelateret livskvalitet. 2021."},{"key":"e_1_3_8_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/23814683231159023"},{"key":"e_1_3_8_60_1","doi-asserted-by":"publisher","DOI":"10.3917\/dec.bajos.2008.01.0021"},{"key":"e_1_3_8_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1208087"},{"key":"e_1_3_8_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-017-0080-9"},{"key":"e_1_3_8_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1483-5"},{"key":"e_1_3_8_64_1","unstructured":"The Danish Organization of General Practitioners. Honorarer og ydelser. [cited 2024 Dec 2]. Available from: https:\/\/laeger.dk\/foreninger\/plo\/overenskomsten-og-aftaler\/honorarer"},{"key":"e_1_3_8_65_1","unstructured":"Finansministeriet. Dokumentationsnotat\u2013den samfunds\u00f8konomiske diskonteringsrente 2021. 2021."},{"key":"e_1_3_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.09.1815"},{"key":"e_1_3_8_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2474891"},{"key":"e_1_3_8_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05632-0"},{"key":"e_1_3_8_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1852870"},{"key":"e_1_3_8_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.008"},{"key":"e_1_3_8_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.10.056"},{"key":"e_1_3_8_72_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-8-200910200-00007"},{"key":"e_1_3_8_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2207-3"},{"key":"e_1_3_8_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2322543"},{"key":"e_1_3_8_75_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075552"},{"key":"e_1_3_8_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir281"},{"key":"e_1_3_8_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.071"},{"key":"e_1_3_8_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101872"},{"key":"e_1_3_8_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25699"},{"key":"e_1_3_8_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.10.015"},{"key":"e_1_3_8_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29254"},{"key":"e_1_3_8_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.198"},{"key":"e_1_3_8_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.04.027"},{"key":"e_1_3_8_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.09.1845"},{"key":"e_1_3_8_85_1","unstructured":"Euractiv. Denmark puts prevention at centre of new cancer plan 2025. Available from: https:\/\/www.euractiv.com\/section\/health-consumers\/news\/denmark-puts-prevention-at-centre-of-new-cancer-plan\/"},{"key":"e_1_3_8_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/14034948241232462"},{"key":"e_1_3_8_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2014.12.008"},{"key":"e_1_3_8_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.04.060"},{"key":"e_1_3_8_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2016.11.004"},{"key":"e_1_3_8_90_1","volume-title":"[Sex in Denmark: Key findings from Project SEXUS 2017\u20132018]","author":"Frisch M","year":"2019","unstructured":"Frisch M, Moseholm E, Andersson M, et al. [Sex in Denmark: Key findings from Project SEXUS 2017\u20132018]. Statens Serum Institut; 2019."},{"key":"e_1_3_8_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.31678"},{"key":"e_1_3_8_92_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-03057-w"},{"key":"e_1_3_8_93_1","unstructured":"Euractiv. Valuing preventative interventions in HTA: the impact of discounting practices 2024. Available from: https:\/\/www.euractiv.com\/section\/health-consumers\/opinion\/valuing-preventative-interventions-in-hta-the-impact-of-discounting-practices\/"},{"key":"e_1_3_8_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.01.005"},{"key":"e_1_3_8_95_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826090-00004"},{"key":"e_1_3_8_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdm072"}],"container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2626567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:44:50Z","timestamp":1773661490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2626567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,16]]}},"alternative-id":["10.1080\/14737167.2026.2626567"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2626567","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}